Angel investors
Accredited individuals who may support formation-stage execution and introductions.
Investor information
Bonpiece is evaluating a phased institute supported by specialty clinical locations, tuition-bearing programs and shared infrastructure.
These are management targets and planning assumptions, not commitments or an offer to sell securities. Timing depends on financing, sponsor eligibility, faculty recruitment, facilities and accreditation.
The planning timeline references a first CODA application window in 2028 and a first cohort target in 2029, subject to all required approvals.
| Planning category | Amount | Purpose |
|---|---|---|
| Central campus | $6M | Simulation, imaging, surgery and shared clinical infrastructure |
| Clinical integration | $6M | Qualifying practice upgrades, systems and network integration |
| Pre-opening | $3M | Accreditation, recruiting, academic development and launch costs |
| Working capital | $5M | Operating runway, payer lag and staged program development |
| Contingency | $3M | Reserve for timing, construction and accreditation variability |
Accredited individuals who may support formation-stage execution and introductions.
Funds interested in education, healthcare services and technology-enabled platforms.
Healthcare investors aligned with clinical scale, specialty succession and shared services.
Long-duration capital partners interested in education, healthcare and regional impact.
| Q1 2027 | Sponsor and governance confirmation |
|---|---|
| Q2 2027 | Program directors, faculty and clinical diligence |
| Q3 2027 | Target initial financing close |
| 2028–2029 | Applications, site review and conditional cohort launch |
Investor materials, if made available, require verified access, an executed nondisclosure agreement and confirmation of accredited investor status. This public page is informational only and is not an offer or solicitation. No investment can be made through this website.